Related Experiment Videos
Chemotherapy and skin reactions.
Gabriella Fabbrocini1, Norma Cameli, Maria Concetta Romano
1Division of Clinical Dermatology, Department of Systematic Pathology, University of Naples Federico II, Naples, Italy. gafabbro@unina.it
Summary
Chemotherapy improves cancer survival but causes common skin side effects like rash and xerosis. Managing these cutaneous toxicities is crucial for patient quality of life and treatment success.
Area of Science:
- Oncology
- Dermatology
- Clinical Pharmacology
Background:
- Advances in cancer chemotherapy have increased patient survival rates.
- Chemotherapy use is associated with a rise in cutaneous side effects, impacting patient quality of life.
- Effective management of chemotherapy-induced skin toxicity is essential for optimal treatment and patient well-being.
Purpose of the Study:
- To investigate the incidence, type, and evolution of cutaneous side effects in cancer patients undergoing chemotherapy.
- To provide detailed clinical case reports on chemotherapy-related skin toxicities.
Main Methods:
- Clinical examination of 100 cancer patients undergoing chemotherapy.
- Documentation of the type, frequency, treatment, and progression of observed skin side effects.
Main Results:
- Common chemotherapy-induced cutaneous side effects include skin rash, xerosis (dry skin), pruritus (itching), paronychia (nail inflammation), hair abnormalities, and mucositis (mouth sores).
- Detailed clinical observations of these side effects were recorded.
Conclusions:
- Despite increased specificity and reduced systemic toxicity of modern oncological therapies, cutaneous side effects remain prevalent.
- These skin toxicities significantly affect patients' quality of life and require appropriate management strategies.
Related Concept Videos
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...